Infectious diseases remain a persistent global health challenge, requiring accurate and timely diagnosis for effective management and control. Molecular diagnostics, a rapidly evolving field at the intersection of biology and technology, offers powerful tools for the detection and characterization of infectious agents at the molecular level. By analyzing nucleic acids or proteins specific to pathogens, molecular diagnostic tests provide rapid and precise identification of infectious diseases, often surpassing the capabilities of traditional culture-based methods. Techniques such as polymerase chain reaction (PCR), nucleic acid sequencing, and immunoassays enable clinicians to detect a wide range of pathogens with high sensitivity and specificity, facilitating early intervention and targeted treatment strategies. Additionally, molecular diagnostics play a crucial role in monitoring antimicrobial resistance patterns, identifying emerging pathogens, and guiding public health interventions to prevent outbreaks and mitigate the spread of infectious diseases.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation